News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cypress Pharmaceutical Receives FDA Approval of Levetiracetam Oral Solution


1/16/2009 11:48:12 AM

MADISON, Miss.--(BUSINESS WIRE)--Cypress Pharmaceutical, Inc., announced today that the U.S. Food and Drug Administration (FDA) has granted final approval of the company’s abbreviated new drug application (ANDA) for Levetiracetam Oral Solution, 100 mg/mL.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES